APA (7th ed.) Citation

Neblett II, M. F., Ducharme, M. T., Meridew, J. A., Haak, A. J., Tschumperlin, D. J., & Stewart, E. A. (2023). EVALUATION OF THE IN VIVO EFFICACY OF THE JAK INHIBITOR AZD1480 AGAINST UTERINE LEIOMYOMAS IN A PATIENT-DERIVED XENOGRAFT MOUSE MODEL. Fertility & Sterility, 120(1), e7. https://doi.org/10.1016/j.fertnstert.2023.05.015

Chicago Style (17th ed.) Citation

Neblett II, Michael F., Merrick T. Ducharme, Jeffrey A. Meridew, Andrew J. Haak, Daniel J. Tschumperlin, and Elizabeth A. Stewart. "EVALUATION OF THE IN VIVO EFFICACY OF THE JAK INHIBITOR AZD1480 AGAINST UTERINE LEIOMYOMAS IN A PATIENT-DERIVED XENOGRAFT MOUSE MODEL." Fertility & Sterility 120, no. 1 (2023): e7. https://doi.org/10.1016/j.fertnstert.2023.05.015.

MLA (9th ed.) Citation

Neblett II, Michael F., et al. "EVALUATION OF THE IN VIVO EFFICACY OF THE JAK INHIBITOR AZD1480 AGAINST UTERINE LEIOMYOMAS IN A PATIENT-DERIVED XENOGRAFT MOUSE MODEL." Fertility & Sterility, vol. 120, no. 1, 2023, p. e7, https://doi.org/10.1016/j.fertnstert.2023.05.015.